Analyst firms · UBS · MMM
UBS MMM price target and rating history
3M Company (MMM) · Health Care
UBS rates 3M Company (MMM) Buy with a $184 price target, as of its latest action on Nov 13, 2024. It has published 4 rating actions on MMM since September 2021, including 2 upgrades and 0 downgrades. Across 4 firms with a MMM price target in the last 12 months, the median target is $184.
- Current rating
- Buy
- Price target
- $184
- Median target, all firms
- $184
- Actions on MMM
- 4
UBS price target on MMM
Every UBS rating on MMM
- Nov 13, 2024
- Sep 9, 2022
- Mar 11, 2022
- Sep 17, 2021
How other firms rate MMM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Equal Weight | $195 | Sep 25, 2026 |
| Bernstein | Mkt Perform | $171 | Sep 25, 2026 |
| Goldman Sachs | Buy | $190 | Jun 15, 2026 |
| Deutsche Bank | Hold | $178 | Dec 8, 2025 |
Questions about UBS and MMM
- What is UBS's price target for MMM?
- UBS's latest stated price target for 3M Company (MMM) is $184, from its action on Nov 13, 2024.
- What is UBS's rating on MMM?
- UBS rates MMM Buy, a bullish rating, as of Nov 13, 2024.
- When did UBS last change its view on MMM?
- On Nov 13, 2024, UBS upgrades to Buy from Neutral, price target $184.
- How does UBS's MMM target compare with other analysts?
- Across 4 firms with a MMM price target in the last 12 months, the median target is $184.
More MMM rating histories
- Wells Fargo7
- Bernstein4
- Deutsche Bank10
- Morgan Stanley9
- Wolfe Research3
- RBC Capital Markets7
- Barclays8
- Citigroup3
- Credit Suisse7
- Mizuho3
All UBS ratingsMMM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.